Publicacións (727) Publicacións de CARLOS MACAYA MIGUEL

2024

  1. Origen del stent coronario: una historia de éxito entre científicos innovadores e industria biotecnológica

    REC: Interventional Cardiology, Vol. 6, Núm. 4, pp. 321-331

  2. Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)

    Revista Espanola de Cardiologia, Vol. 77, Núm. 11, pp. 936-946

2023

  1. Duration and clinical outcomes of dual antiplatelet therapy following percutaneous coronary intervention for acute coronary syndrome: A multicentre “real-world practice” registry-based study

    Frontiers in Cardiovascular Medicine, Vol. 10

  2. Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry

    Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78

  3. Mid-Term Angiographic and Intracoronary Imaging Results Following Intracoronary Lithotripsy in Calcified Coronary Artery Disease: Results From Two Tertiary Referral Centres

    Cardiovascular Revascularization Medicine, Vol. 52, pp. 59-66

  4. Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 519-530

2022

  1. Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial

    European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330

  2. Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry

    Heart (British Cardiac Society), Vol. 108, Núm. 2, pp. 130-136

  3. Avances tecnológicos en el tratamiento de las enfermedades cardiovasculares: perspectiva de médicos y administradores

    REC: Interventional Cardiology, Vol. 4, Núm. 3, pp. 243-245

  4. Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry

    International Journal of Clinical Practice, Vol. 2022

  5. Design and Rationale for a Real-World Prospective, Multicenter Registry of Myocardial Revascularization Failure and Secondary Revascularization: The REVASEC Study

    Cardiovascular Revascularization Medicine, Vol. 40, pp. 50-56

  6. Diabetes mellitus y seguridad a largo plazo del diferimiento de la revascularización coronaria basado en FFR e iFR

    REC: Interventional Cardiology, Vol. 4, Núm. 2, pp. 99-106

  7. Incidence, clinical impact and predictors of thrombocytopenia after transcatheter aortic valve replacement

    International Journal of Cardiology, Vol. 352, pp. 21-26

  8. Long-term outcomes after deferral of revascularization of in-stent restenosis using fractional flow reserve

    Catheterization and Cardiovascular Interventions, Vol. 99, Núm. 3, pp. 723-729

  9. Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections

    Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 273-278

  10. Public healthcare expenditure and COVID-19 mortality in Spain and in Europe. Response to the Letter from the Editor by Velasco Montes et al

    Revista Clinica Espanola

  11. The effect of weekends and public holidays on the care of acute coronary syndrome in the Spanish National Health System

    Revista Espanola de Cardiologia, Vol. 75, Núm. 9, pp. 757-763

  12. Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement in the Era of New-Generation Devices

    The Journal of invasive cardiology, Vol. 34, Núm. 4, pp. E299-E309

  13. Vascular Injury After Stenting　- Insights of Systemic Mechanisms of Vascular Repair

    Circulation journal : official journal of the Japanese Circulation Society, Vol. 86, Núm. 6, pp. 966-974

  14. Vascular healing responses to paclitaxel coated balloons or everolimus eluting stents for the treatment of in-stent restenosis. Insights from optical coherence tomography

    Coronary Artery Disease, Vol. 33, Núm. 8, pp. 609-617